Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 10:01 PM
Study NCT ID:
NCT01585558
Status:
COMPLETED
Last Update Posted:
2018-05-21
First Post:
2012-04-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
Sponsor:
Shionogi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05-16
Start Date Type:
ACTUAL
Primary Completion Date:
2008-08-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09-18
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-18
First Submit QC Date:
None
Study First Post Date:
2012-04-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-03-20
Results First Submit QC Date:
None
Results First Post Date:
2013-06-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-19
Last Update Post Date:
2018-05-21
Last Update Post Date Type:
ACTUAL